Amphastar Pharmaceuticals reported its third-quarter 2025 results, revealing quarterly revenues of US$191.84 million and net income of US$17.35 million, with sales of Baqsimi and Primatene Mist ...

Amphastar Pharmaceuticals' third quarter results for 2025 came in ahead of Wall Street's revenue and profit expectations, despite essentially flat sales compared to the prior year. The quarter was ...

An over-the-counter asthma inhaler, Primatene Mist, was initially thought to have contributed to the death In the late '80s and early '90s, you couldn't crack a teen magazine without seeing pictures ...

Amphastar Pharmaceuticals Inc ((AMPH)) has held its Q3 earnings call. Read on for the main highlights of the call. Amphastar Pharmaceuticals’ recent earnings call revealed a resilient performance, ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...

An attempt to protect the ozone layer has effectively removed the only over-the-counter asthma inhaler from the market, forcing some asthma sufferers to find room in their budgets for visits to the ...

You don't need to spend a lot of money or go on a cooking course to prepare pasta that looks like it came straight out of a restaurant. Sometimes the secret lies in a simple touch, an ingredient that ...

Asthma medicine needs to get into your lungs to work, but do you know how it gets there? Inhalers and nebulizers — that's how! Your doctor will tell you which device is best for you. Nebulizers are ...